Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  KKR & Co. L.P.    KKR

KKR & CO. L.P. (KKR)
Mes dernières consult.
Most popular
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

KKR Confirms $3.74 Billion Deal to Buy Gardner Denver

share with twitter share with LinkedIn share with facebook
share via e-mail
03/08/2013 | 02:26am CEST

Gardner Denver Inc. (>> Gardner Denver, Inc.) and Kohlberg Kravis Roberts & Co. confirmed the industrial-pumps manufacturer has agreed to be acquired for roughly $3.74 billion.

The New York private-equity firm will pay $76 for each Gardner Denver share, a 2.9% premium to Thursday's close. Shares were recently trading 1.4% higher at $74.91 premarket. The stock has climbed 7.8% since the start of the year.

The deal values Gardner Denver at about $3.9 billion, including the assumption of debt.

KKR had bid $75 a share for the Wayne, Pa.-based company in February and increased the offer after Gardner Denver sought a higher price.

For KKR, the deal would mark the buyout firm's third purchase in the industrials space in the past few years. KKR agreed in April 2011 to acquire Capsugel, a unit of pharmaceutical giant Pfizer Inc. (>> Pfizer Inc.) that makes drugs in capsule form. Later that year, KKR agreed to acquire Capital Safety Inc., a large provider of safety products and equipment for construction and other workers.

KKR ended up being the only serious suitor for Gardner Denver in an up-and-down sales process that dragged on in recent months.

Gardner Denver, which employs about 6,400 people and posted sales of about $2.4 billion last year, pursued a deal with rival SPX Corp. (>> SPX Corporation) late last year after garnering interest from a number of private-equity firms. SPX offered $4 billion for the company but later dropped the bid amid negative reactions from shareholders.

Write to Melodie Warner at [email protected]

Order free Annual Report for Gardner Denver Inc.

Visit http://djnewswires.ar.wilink.com/?link=GDI or call 1-888-301-0513

Stocks mentioned in the article : Gardner Denver, Inc., SPX Corporation, Pfizer Inc.
Stocks mentioned in the article
ChangeLast1st jan.
KKR & CO. L.P. 0.10% 21.005 Delayed Quote.-0.38%
SPX CORP -0.76% 32.82 Delayed Quote.4.87%
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on KKR & CO. L.P.
04/17KKR L P : backed United Group announces increased commitment to Serbia
04/13KKR L P : agrees to sell its 75% equity stake in South Staffordshire Plc to Arju..
04/12OPTIV SECURITY : Launches Comprehensive Assessments Portfolio; Advances Strategy..
04/11KKR : To Appoint David Haines as Executive Chairman of Global Spreads Business
04/11KKR L P : To Appoint David Haines as Executive Chairman of Global Spreads Busine..
04/09FS INVESTMENTS : and KKR Close Transaction, Creating Largest BDC Platform
04/06KKR & CO. L.P. : Blog Exposure - Global Investment Firm KKR Increases Stake in C..
04/05KKR L P : Announces Release of 2017 Schedule K-1 Tax Forms for & Co. L.P. and Fi..
04/05Carlyle splashes A$1 billion on Australian winemaker with eye on China
04/04OPTIV SECURITY : Named a “Major Player” in the IDC MarketScape for C..
More news
News from SeekingAlpha
04/17GE +3.5% on reported interest in Jenbacher unit 
04/09THE JOURNEY AND THE DESTINATION : Q1 Results And Looking Ahead 
04/09FS Investments closes deal with KKR 
03/21Main Street Capital's NAV, Dividend, And Valuation Compared To 11 BDC Peers (.. 
03/09Private equity firms use short-term bank loans to boost returns 
Financials ($)
Sales 2018 3 398 M
EBIT 2018 2 031 M
Net income 2018 -
Debt 2018 -
Yield 2018 3,35%
P/E ratio 2018 -
P/E ratio 2019 7,23
Capi. / Sales 2018 5,13x
Capi. / Sales 2019 4,20x
Capitalization 17 431 M
Chart KKR & CO. L.P.
Duration : Period :
KKR & Co. L.P. Technical Analysis Chart | KKR | US48248M1027 | 4-Traders
Technical analysis trends KKR & CO. L.P.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 14
Average target price 25,3 $
Spread / Average Target 21%
EPS Revisions
Henry R. Kravis Co-Chairman & Co-Chief Executive Officer
George Rosenberg Roberts Co-Chairman & Co-Chief Executive Officer
Joseph Yong Bum Bae Co-President, Co-COO & Director
Scott Charles Nuttall Co-President, Co-COO & Director
William Joseph Janetschek Chief Financial Officer
Sector and Competitors
1st jan.Capitalization (M$)
KKR & CO. L.P.-0.38%17 431
T. ROWE PRICE GROUP3.76%26 632
LEGAL & GENERAL-1.32%23 214
AMUNDI-6.33%16 504